A case report titled as a fatal overdose actually describes discharge after recovery. Its clonazepam and cardiovascular-drug exposure cannot be summarized faithfully from the title alone.
A twenty-two-year-old man reportedly ingested unknown quantities of clonazepam, prazosin, ivabradine, and propranolol. He developed severe bradycardia, hypotension, and respiratory failure.
Treatment included ventilation, cardiovascular support, lipid emulsion, and temporary pacing. The body states that he was weaned from ventilation, had the pacemaker removed, and was discharged on day ten with improved cardiac function.
The word fatal in the title is inconsistent with the described outcome. A summary must preserve that discrepancy rather than invent a death. The unknown quantities and multiple active drugs also prevent assigning a precise contribution to clonazepam.
Several interventions occurred together, so improvement cannot establish that lipid emulsion or any single measure independently produced recovery.
Use the actual clinical course when classifying outcome and severity. This is a life-threatening reported mixed exposure with survival, not a measured clonazepam fatality threshold. It does not establish which drug caused each sign or a general treatment success rate. The paper is especially instructive about checking narrative findings before relying on headline terminology.
Original analysis of the supplied journal article, identified as PMC13249375.